China Biotech Services Holdings Limited

SEHK:8037 Stock Report

Market Cap: HK$394.9m

China Biotech Services Holdings Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure3.5yrs
Board average tenure6.3yrs

Recent management updates

Recent updates

China Biotech Services Holdings Limited's (HKG:8037) Popularity With Investors Under Threat As Stock Sinks 31%

Mar 07
China Biotech Services Holdings Limited's (HKG:8037) Popularity With Investors Under Threat As Stock Sinks 31%

Earnings Not Telling The Story For China Biotech Services Holdings Limited (HKG:8037) After Shares Rise 46%

Jan 18
Earnings Not Telling The Story For China Biotech Services Holdings Limited (HKG:8037) After Shares Rise 46%

We Think China Biotech Services Holdings (HKG:8037) Might Have The DNA Of A Multi-Bagger

Jan 06
We Think China Biotech Services Holdings (HKG:8037) Might Have The DNA Of A Multi-Bagger

Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?

Dec 09
Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?

These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely

Aug 24
These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely

A Look At The Fair Value Of China Biotech Services Holdings Limited (HKG:8037)

Nov 05
A Look At The Fair Value Of China Biotech Services Holdings Limited (HKG:8037)

Is China Biotech Services Holdings (HKG:8037) A Risky Investment?

Oct 13
Is China Biotech Services Holdings (HKG:8037) A Risky Investment?

What China Biotech Services Holdings Limited's (HKG:8037) 35% Share Price Gain Is Not Telling You

Jun 28
What China Biotech Services Holdings Limited's (HKG:8037) 35% Share Price Gain Is Not Telling You

China Biotech Services Holdings (HKG:8037) Could Become A Multi-Bagger

Mar 16
China Biotech Services Holdings (HKG:8037) Could Become A Multi-Bagger

China Biotech Services Holdings (HKG:8037) Knows How To Allocate Capital Effectively

Dec 01
China Biotech Services Holdings (HKG:8037) Knows How To Allocate Capital Effectively

Under The Bonnet, China Biotech Services Holdings' (HKG:8037) Returns Look Impressive

Jul 26
Under The Bonnet, China Biotech Services Holdings' (HKG:8037) Returns Look Impressive

China Biotech Services Holdings' (HKG:8037) Robust Earnings Are Supported By Other Strong Factors

Apr 05
China Biotech Services Holdings' (HKG:8037) Robust Earnings Are Supported By Other Strong Factors

Investors Shouldn't Overlook China Biotech Services Holdings' (HKG:8037) Impressive Returns On Capital

Mar 23
Investors Shouldn't Overlook China Biotech Services Holdings' (HKG:8037) Impressive Returns On Capital

Did You Miss China Biotech Services Holdings' (HKG:8037) Whopping 825% Share Price Gain?

Feb 23
Did You Miss China Biotech Services Holdings' (HKG:8037) Whopping 825% Share Price Gain?

Chun-Shun Ko Just Bought 27% More Shares In China Biotech Services Holdings Limited (HKG:8037)

Jan 28
Chun-Shun Ko Just Bought 27% More Shares In China Biotech Services Holdings Limited (HKG:8037)

What Is The Ownership Structure Like For China Biotech Services Holdings Limited (HKG:8037)?

Jan 11
What Is The Ownership Structure Like For China Biotech Services Holdings Limited (HKG:8037)?

The Trend Of High Returns At China Biotech Services Holdings (HKG:8037) Has Us Very Interested

Dec 08
The Trend Of High Returns At China Biotech Services Holdings (HKG:8037) Has Us Very Interested

CEO

China Biotech Services Holdings has no CEO, or we have no data on them.


Leadership Team

NamePositionTenureCompensationOwnership
Xiaolin Liu
Executive Chairman & Compliance Officer6.6yrsHK$11.67m55.08%
HK$ 217.5m
Song Huang
CTO & Executive Director4.3yrsHK$998.00kno data
Xun He
Executive Directorno dataHK$1.71m0%
HK$ 0
Xuanming Yang
Chief Scientific Officerno datano datano data
Yi Yao
Consultant2.8yrsHK$1.70mno data
Miu Shun Wong
Company Secretary6.4yrsno datano data

3.5yrs

Average Tenure

56yo

Average Age

Experienced Management: 8037's management team is considered experienced (3.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Xiaolin Liu
Executive Chairman & Compliance Officer6.6yrsHK$11.67m55.08%
HK$ 217.5m
Song Huang
CTO & Executive Director6.5yrsHK$998.00kno data
Xun He
Executive Director5.6yrsHK$1.71m0%
HK$ 0
Ting Yuk Wu
Member of Scientific Advisory Boardno datano datano data
Guoxiang Yan
Independent Non-Executive Director6.6yrsHK$240.00kno data
Chun Kit Ho
Independent Non-Executive Director5.3yrsHK$240.00kno data
Hongji Qian
Independent Non-Executive Director6yrsHK$240.00kno data
Gang Song
Member of Scientific Advisory Boardno datano datano data
Paul Waring
Member of Scientific Advisory Boardno datano datano data
Yang Xin Fu
Chairman of Scientific Advisory Boardno datano datano data
Yao Shiego
Member of Scientific Advisory Boardno datano datano data
Shengli Bi
Member of Scientific Advisory Boardno datano datano data

6.3yrs

Average Tenure

53yo

Average Age

Experienced Board: 8037's board of directors are considered experienced (6.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.